# Lexington Medical Center – FDA Inspection, Jan 15, 2020

Source: https://www.keypedia.com/records/fda_inspections/lexington-medical-center/897aedc7-83a0-4ff1-a70a-7fed9f98a29f
Source feed: FDA_Inspections

> FDA inspection 1115175 of Lexington Medical Center, January 15, 2020. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1115175
- Company Name: Lexington Medical Center
- Inspection Date: 2020-01-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1253271 - 2024-10-30](https://www.keypedia.com/records/fda_inspections/lexington-medical-center/86e7a9d1-971c-4a6f-814f-d3a8395f6c6f)
- FDA Inspection 1038773 - 2018-01-10
- [FDA Inspection 957156 - 2016-01-21](https://www.keypedia.com/records/fda_inspections/lexington-medical-center/86d60768-f3be-4ba7-ba16-fbbf537f245b)
- FDA Inspection 884380 - 2014-06-13
- FDA Inspection 774594 - 2012-02-16

Company: https://www.keypedia.com/companies/lexington-medical-center/9dc08ec7-0424-445a-9b58-63c094fd3012

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
